Drug Development

Blog Post

Eledon Announces Positive Topline Results from a Phase 2a Study of Tegoprubart to Treat ALS

By Sujatha Gurunathan | June 1, 2022
Blog Post

Clinical Trial Alert: Phase 3 Study of investigational drug in Adults Living with ALS

By Sujatha Gurunathan | May 17, 2022
Man in an electric wheelchair on a footpath in a suburban setting.
Featured Article

Understanding Amyotrophic Lateral Sclerosis

By MDA Staff | May 13, 2022
Scientific conference speakers
Featured Article

A Successful In-Person Conference

By MDA Staff | May 13, 2022
Blog Post

Simply Stated: Inclusion Body Myositis, Revisited

By Sujatha Gurunathan | April 27, 2022
MG clinical trial
Blog Post

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults Living with gMG

By MDA Staff | April 6, 2022
dermatomyositis clinical trial
Blog Post

Clinical Trial Alert: Phase 2 Study of Ravulizumab (Ultomiris) in Adults Living with Dermatomyositis

By MDA Staff | April 5, 2022
Clinical & Scientific Conference
Blog Post

2022 Clinical & Scientific Conference: March 16 Highlights

By Sujatha Gurunathan | March 16, 2022
dystrophin
Blog Post

Simply Stated: What is Duchenne Muscular Dystrophy?

By Sujatha Gurunathan | February 16, 2022
Blog Post

FDA Approves argenx’s Vyvgart for Treatment of gMG

By Sujatha Gurunathan | December 20, 2021